Question

Care este perioada de recuperare după terapia cu celule stem pentru Ciroză Hepatică?

Recovery and assessment timescales in cirrhosis extend from weeks to months. Initial post-infusion inflammatory responses subside within 1–2 weeks. Changes in liver synthetic function (albumin, bilirubin, INR) are typically measured at 2, 4, 8, and 12 weeks post-infusion to assess response. Hepatic imaging (ultrasound, transient elastography) may be repeated at 3 and 6 months to evaluate fibrosis progression. Clinical improvement in ascites, encephalopathy, or variceal bleeding risk may become apparent over 2–4 weeks but often requires months to solidify. Importantly, cirrhosis does not 'recover' in the traditional sense; the goal is stabilisation and slowed deterioration, not functional restoration.

Ce arată dovezile pentru Ciroză Hepatică

Cirrhosis trials represent the most mature evidence base among stem-cell-investigated liver diseases. Published studies have documented improvements in liver synthetic function (albumin, prothrombin time), reductions in portal hypertension parameters, and enhanced hepatic blood flow following MSC infusion. Several trials reported reduced variceal bleeding incidence and slower progression to hepatic encephalopathy. However, many studies remain observational and uncontrolled; head-to-head comparisons with standard care (diuretics, beta-blockers, endoscopic banding) are sparse. Disease heterogeneity — varying aetiology (viral hepatitis, alcohol, autoimmune) and cirrhosis stage — limits generalisation of results. Long-term transplant-free survival data are limited; many patients eventually require liver transplantation despite MSC treatment.

Sunt un candidat? → · Liver Cirrhosis: full overview → · Cost Ciroză Hepatică → · Cost →

Revizuit medical de echipa editorială a StemCellAtlas cu Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.

Terapie celulară de nivel european, fără prețuri europene.

Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.

Evaluare medicală gratuită